Ophthalmology Clinic M&A: Enhancing Profitability Through Succession. Practical Points and Valuation Factors

📖 Approx. 8 minutesPublished: 2026.05.05 ／ Updated 2026.05.08

Business Succession and M&A for Ophthalmology Clinics: A New Option to Support Community Healthcare

With the aging population, the number of patients with ophthalmic conditions such as cataracts and glaucoma continues to rise. In particular, treatments incorporating elements of private pay services, such as cataract surgery, advanced intraocular lens therapies, and myopia control treatments, are becoming crucial pillars for enhancing the profitability of ophthalmology clinics. On the other hand, many medical corporations and clinic directors face challenges such as the aging of physicians and a lack of successors, leading them to consider business succession or M&A. This article focuses on business succession and M&A for ophthalmology clinics, explaining their market characteristics, typical valuation ranges, factors that increase value, and practical considerations from a specialized perspective on medical M&A.

Market Characteristics and Growth Potential of Ophthalmology Clinics

The market for business succession and M&A of ophthalmology clinics has unique characteristics compared to other medical specialties. Firstly, Japan’s rapidly aging population is increasing the number of patients with ophthalmic conditions such as cataracts, glaucoma, and age-related macular degeneration, leading to a stable increase in demand for medical services. In particular, the number of cataract surgeries is one of the key indicators that significantly influences a clinic’s profitability.

Furthermore, a characteristic of the ophthalmology field is that it is relatively easy to secure revenue streams from private pay services in addition to insurance-based medical care. For example, cataract surgery using multifocal intraocular lenses greatly contributes to improving patients’ quality of life while allowing for higher pricing, thus enhancing clinic profitability. Additionally, services such as contact lens prescriptions, dry eye treatment, and myopia control treatments using orthokeratology or low-concentration atropine eye drops are also attracting attention as treatment menus that generate continuous revenue.

These private pay services often require advanced specialized knowledge and the latest medical equipment, making technical expertise and capital investment crucial for a clinic’s competitiveness. Therefore, in M&A, it is an important consideration whether the acquiring party can evaluate these technologies and equipment and integrate them into their own business strategy. From the perspective of regional medical care planning, the succession of highly specialized ophthalmology clinics holds the potential to contribute to the maintenance and strengthening of the overall regional healthcare delivery system.

Valuation Range and Metrics for Ophthalmology Clinic Succession

The transfer price for an ophthalmology clinic is generally calculated by adding goodwill (Noren) to the net asset value. For goodwill valuation, EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is an important metric. In the case of ophthalmology clinics, the multiple applied to EBITDA varies depending on the clinic’s characteristics.

Clinic Type	Estimated EBITDA Multiple	Estimated Valuation Range
Outpatient-focused (primarily insurance-based)	3-4x	¥30 million – ¥100 million
With Cataract Surgery Services	4-5x	¥100 million – ¥300 million
LASIK/ICL, primarily private pay	4-6x	¥100 million – ¥500 million+

The table above is a general guideline. The actual transfer price can vary significantly due to a wide range of factors, including location, patient numbers, repeat patient rates, staff quality, the obsolescence of medical equipment, the impact of medical fee revisions, and even the age and health of the transferring physician. In particular, the annual number of cataract surgeries performed, the adoption rate of multifocal intraocular lenses, and the implementation of advanced private pay treatments such as myopia control are directly linked to profitability and are therefore important factors in valuation.

Furthermore, for medical corporations, the existence and valuation of equity shares, as well as the composition of shareholders, can also influence the M&A structure and price. Complex issues such as the repayment of funds and organizational changes of the medical corporation (e.g., conversion to a partnership) must also be considered.

Factors Contributing to High Valuation in Ophthalmology Clinic Succession

To enhance the transfer price and negotiation leverage in the business succession and M&A of ophthalmology clinics, several key factors are important. These are points that acquiring parties prioritize when evaluating a clinic’s future potential and profitability.

1. Surgical Track Record and Specialized Areas

The foundation of an ophthalmology clinic’s profitability lies in its surgical performance, especially cataract surgery. Generally, clinics performing over 200 cataract surgeries annually are considered to have stable surgical skills and a solid patient base. Furthermore, a track record of advanced surgeries, from cutting-edge treatments to surgeries using multifocal intraocular lenses (which have transitioned from private pay to insurance coverage) and vitreoretinal surgeries, significantly enhances a clinic’s specialization and profitability.

In addition to specialized cataract clinics, clinics with strengths in specific areas such as glaucoma, retinal and vitreous diseases, pediatric ophthalmology and strabismus, and the increasingly in-demand myopia control treatments (for children) tend to receive high valuations because they can secure a niche yet stable patient base.

2. Latest and High-Performance Diagnostic and Treatment Equipment

The quality and efficiency of ophthalmic care are heavily dependent on the medical equipment used. Optical Coherence Tomography (OCT), visual field analyzers like Humphrey and Goldmann, high-resolution fundus cameras, axial length measurement devices, and corneal topography systems are essential for accurate diagnosis and effective treatment planning. Having the latest equipment in sufficient quantities serves as a strong selling point for a clinic’s technical capabilities and future prospects.

In particular, surgical equipment (e.g., phacoemulsification systems, intraocular lens injectors) and laser treatment devices are valued as assets that directly impact the transfer price. For equipment under lease contracts, the terms of transfer and remaining lease period are also important negotiation points.

3. Stable Patient Base and Repeat Visit Rate

The number of local general outpatient patients and their high repeat visit rate are crucial factors that guarantee a clinic’s sustainable profitability. Clinics that have earned the trust of the elderly population and local residents are particularly attractive acquisition targets for buyers. A detailed analysis of the patient demographic composition, disease prevalence, and the proportion of patients receiving continuous treatment is required.

Practical Considerations in Ophthalmology Clinic Succession

When proceeding with M&A or business succession for an ophthalmology clinic, there are several practical points that are often overlooked. Understanding these in advance and taking appropriate measures will lead to a smooth succession and help avoid future troubles.

1. Confirmation of Medical Fees and Facility Standards

The acquiring party must verify the accuracy of medical fee calculations and whether the clinic meets various facility standards (e.g., those required for specific ophthalmic surgeries). In particular, the ratio of insurance-based to private pay services, and any instances of billing errors or fraudulent claims in insurance-based services, will be thoroughly investigated during due diligence. The impact of future medical fee revisions must also be taken into account.

2. Lease and Maintenance Contracts for Medical Equipment

Many high-value ophthalmic medical devices are typically acquired through lease agreements. In M&A, it is necessary to confirm whether these lease contracts can be transferred to the acquiring party or if new contracts are required. Additionally, the terms of maintenance and service contracts for medical equipment must be reviewed, and the possibility of transferring them should be considered.

3. Securing a Surgeon and Transfer of Skills/Know-how

Especially for clinics primarily performing surgery, securing a successor surgeon if the current surgeon cannot continue working is the most critical issue. Key negotiation points include whether the acquiring party can dispatch its own physicians or if the current surgeon can be requested to continue working for a certain period. Furthermore, transferring the “tacit knowledge” of skilled physicians, such as advanced surgical techniques and patient communication know-how, is important from a long-term perspective.

4. Transaction Relationships with Intraocular Lens Manufacturers, etc.

Transaction relationships with manufacturers of intraocular lenses and surgical consumables affect a clinic’s procurement costs. It is necessary to consider whether these business relationships can be smoothly inherited after the M&A, or if more favorable terms can be negotiated.

5. Transfer Procedures for Licenses and Notifications

The succession of a medical corporation or clinic requires numerous procedures related to licenses and notifications, such as change of operator notifications to the public health center and applications for changes in insurance medical institution designation to the regional bureau of health and welfare. These procedures are complex and require specialized knowledge, making it advisable to seek support from M&A advisory firms. In particular, approvals from the general meeting of shareholders of a medical corporation and changes in registered directors may also be necessary.

The business succession and M&A of ophthalmology clinics is not merely a transfer of assets but a crucial process aimed at contributing to regional healthcare, maintaining staff employment, and realizing new growth strategies. For success, it is essential to proceed cautiously and strategically in collaboration with M&A advisors possessing specialized knowledge and experience. As an M&A advisor certified by the Small and Medium Enterprise Agency, MA-Medical possesses extensive experience and know-how specifically in medical institution M&A. We offer optimal succession plans tailored to your clinic’s situation, so please feel free to consult with us.

---

Consult MA-Medical for Medical Succession

MA-Medical is a specialized M&A and business succession support service for medical institutions. As an M&A advisor certified by the Small and Medium Enterprise Agency, we support everything from the transfer of clinics and medical corporations struggling with a lack of successors to strategic acquisitions on a success-fee basis.

• Initial consultation and preliminary assessment are free
• No upfront fees or monthly charges (success fee only)
• Strict confidentiality (proceeding under NDA)
• Services available nationwide in all 47 prefectures and for all medical specialties

Please consult with us early in your consideration phase, whether you simply want to know the market value, have no successor, or are considering joining a group.

Apply for Free Consultation